Global Digital Diabetes Management Market

Digital Diabetes Management Market Size, Share, Growth Analysis, By Product & Service, By Type, By End User, By Region - Industry Forecast 2025-2032

Report ID: SQMIG45E2282 | Region: Global | Published Date: December, 2024
Pages: 174 | Tables: 89 | Figures: 71

Digital Diabetes Management Market Competitive Landscape

The major industry players are trying to enhance their client offers by putting more and more effort into the implementation of cutting-edge technology and sophisticated products. They are creating strategic alliances, considering acquisitions, and taking part in government programs with an objective to increase their market presence and serve better, earning a competitive advantage in a fast-changing market.

Top Player’s Company Profile

  • Medtronic   
  • F. Hoffmann-La Roche   
  • Dexcom, Inc.   
  • Ascensia Diabetes Care Holdings AG   
  • Abbott Laboratories   
  • B. Braun Melsungen AG   
  • Tidepool   
  • Glooko, Inc.   
  • LifeScan, Inc.   
  • AgaMatrix   
  • Tandem Diabetes Care, Inc.   
  • Insulet Corporation   
  • DarioHealth Corporation   
  • One Drop   
  • Ypsomed Holding AG   
  • Arkray   
  • Dottli   
  • Acon Laboratories, Inc.   
  • Care Innovations, LLC   
  • Health2Sync

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Digital Diabetes Management Market size was valued at USD 13.84 Billion in 2023 and is poised to grow from USD 14.99 Billion in 2024 to USD 26.19 Billion by 2032, growing at a CAGR of 8.3% during the forecast period (2025-2032).

The major industry players are trying to enhance their client offers by putting more and more effort into the implementation of cutting-edge technology and sophisticated products. They are creating strategic alliances, considering acquisitions, and taking part in government programs with an objective to increase their market presence and serve better, earning a competitive advantage in a fast-changing market. 'Medtronic   ', 'F. Hoffmann-La Roche   ', 'Dexcom, Inc.   ', 'Ascensia Diabetes Care Holdings AG   ', 'Abbott Laboratories   ', 'B. Braun Melsungen AG   ', 'Tidepool   ', 'Glooko, Inc.   ', 'LifeScan, Inc.   ', 'AgaMatrix   ', 'Tandem Diabetes Care, Inc.   ', 'Insulet Corporation   ', 'DarioHealth Corporation   ', 'One Drop   ', 'Ypsomed Holding AG   ', 'Arkray   ', 'Dottli   ', 'Acon Laboratories, Inc.   ', 'Care Innovations, LLC   ', 'Health2Sync'

Increased use of digital management systems is characterized by growing public awareness of diabetes and its implications. Due to health promotion campaigns and educational programs informing people how to control their health, tools that facilitate proactive management and self-monitoring are in greater demand. Growing public awareness of proper diabetes treatment results in the increased popularity of digital platforms providing easily accessible and accessible materials.

AI-Powered Personalized Care: One of the recent trends in diabetes care is the application of artificial intelligence, where personalized regimens of treatment are being made possible. Data about a patient shall be processed with the help of algorithms containing AI, so the users shall receive advice on medicines, diet, and exercise that is personalized for them. Patients will become more motivated to take an active and participative approach towards diabetes management because they shall be presented with more salient information regarding their situation, thus performing better at compliance and results.

In 2023, North America dominated the market with a share over 38.0% due to various digital blood glucose patient monitoring devices that have recently been approved in the region and advanced technology is available. For instance, in January 2022, Insulet Corporation stated that their Omnipod 5 Automated Insulin Delivery System has been approved by the U.S. FDA. This is a special system that integrates with Dexcom G6 Continuous Glucose Monitoring (CGM). Integrate a SmartBolus Calculator for remote patient monitoring and data sharing through the Omnipod 5 smartphone app. Region-specific market growth will be supported by the aging population and the increasing prevalence of diabetes related to lifestyle changes.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Global Digital Diabetes Management Market

Report ID: SQMIG45E2282

$5,300
BUY NOW GET FREE SAMPLE